Pharma Grade Calcium Sulphate Market Expected to Achieve 8.4% CAGR by 2029: Growth Forecast Insights

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Pharma Grade Calcium Sulphate Market Size By 2025?
Recent years have witnessed significant growth in the pharma grade calcium sulphate market. Expected to expand from $0.89 billion in 2024 to $0.96 billion in 2025, the market showcases a compound annual growth rate (CAGR) of 7.9%. The growth experienced during the historic period resulted from various factors. Increased demand in the pharmaceutical sector, wider use in medical procedures and surgeries, heightened awareness of bone health, advancements in drug delivery systems, and a rise in bone-related illnesses all contributed to this market expansion.

How Big Is the Pharma Grade Calcium Sulphate Market Size Expected to Grow by 2029?
The market for pharmaceutical-grade calcium sulphate is predicted to witness robust growth in the ensuing years, expanding to "$1.33 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 8.4%. This surge during the forecast period can be ascribed to factors such as an increasing elderly population, a rise in bone and joint issues, escalated healthcare investment in budding economies, heightened application of calcium sulphate in regenerative medicine, and the expansion of the pharmaceutical sector. Notable trends for the forecast duration involve a pivot towards organic and natural calcium sulphate sources, strides in the technology used for calcium sulphate synthesis, emphasis on sustainable and environmentally-friendly manufacturing procedures, advancements in controlled-release drug delivery systems, and innovative drug formulations.

View the full report here:
https://www.thebusinessresearchcompany.com/report/pharma-grade-calcium-sulphate-global-market-report

Which Key Market Drivers Powering Pharma Grade Calcium Sulphate Market Expansion and Growth?
The pharma grade calcium sulphate market is anticipated to experience growth due to increasing demand for pharmaceuticals. These medications, designed to diagnose, prevent, or treat diseases in both humans and animals, are seeing a surge in demand primarily because of a rise in chronic diseases. These conditions such as diabetes, heart diseases, and cancer necessitate extended-term medications, thus driving up the demand. Serving as a high-purity excipient in these pharmaceutical formulations, pharma grade calcium sulphate ensures controlled release of active ingredients, stabilized tablet hardness, and consistency. For instance, as per the European Federation of Pharmaceutical Industries and Associations, in 2022, North America made up 52.3% of global pharmaceutical sales, with Europe comprising 22.4%. Thus, the surge in demand for pharmaceuticals is fuelling the expansion of the pharma grade calcium sulphate market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24372&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Pharma Grade Calcium Sulphate Market?
Key players in the pharmaceutical grade calcium sulphate industry are concentrating on the creation of novel products, utilizing synthetic medical-grade bassanite to improve product consistency and purity. The synthetic medical-grade bassanite, which is a highly pure, slightly dehydrated variant of calcium sulphate (CaSO4·0.5H2O), is pivotal in delivering a uniform, contamination-free source of pharma-grade calcium sulphate that adheres to rigorous standards for medical and pharmaceutical use cases. As an example, Sree Chitra Tirunal Institute for Medical Sciences & Technology, based in India, introduced Caspro & Bonyx, ground-breaking drug-delivery bone graft products fashioned using synthetic medical-grade bassanite in February 2025, ensuring high biocompatibility, pureness, and controlled drug delivery for leading-edge orthopaedic applications. Caspro, a self-hardening, mouldable bone cement comprised of calcium sulfate hemihydrate reinforced with phosphate ions, is ideal for bone defect filling and drug delivery at the implantation site that lasts beyond 21 days. Whereas, Bonyx comprises osteoconductive bioceramic beads that can be vacuum-loaded with antibiotics or other liquid-form medications, facilitating continual drug release for over 30 days. These products mark a substantial advancement in localized treatment methods for bone infections and regeneration and showcase how pharma-grade calcium sulphate can be applied to design pioneering biomedical solutions that conform to strict universal standards.

What Are the Emerging Segments in the Pharma Grade Calcium Sulphate Market?
The pharma grade calcium sulphate market covered in this report is segmented -

1) By Type: Calcium Sulphate Dihydrate, Calcium Sulphate Hemihydrate, Calcium Sulphate Anhydrite
2) By Application: Pharmaceutical Excipients, Binders In Tablet Formulations, Calcium Supplements, Diagnostic Agents
3) By Distribution Channel: Direct Distribution, Online Distribution, Wholesale Distribution, Retail Distribution

Subsegments:

1) By Calcium Sulphate Dihydrate: Fine Powder, Granular Form, Micronized Grade
2) By Calcium Sulphate Hemihydrate: Alpha Hemihydrate, Beta Hemihydrate, High Purity Hemihydrate
3) By Calcium Sulphate Anhydrite: Natural Anhydrite, Synthetic Anhydrite, High-Density Anhydrite

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=24372&type=smp

Who Are the Global Leaders in the Pharma Grade Calcium Sulphate Market?
Major companies operating in the pharma grade calcium sulphate market are Thermo Fisher Scientific Inc., Honeywell International Inc., Merck KGaA, Solvay S.A., Avantor Inc., MP Biomedicals LLC, Spectrum Chemical Manufacturing Corp., Anhui Sunhere Pharmaceutical Excipients, SRL Chemical, GFS Chemicals Inc., American Elements, Loba Chemie Pvt. Ltd., Annexe Chem, Noah Technologies Corporation, Junsei Chemical Co. Ltd, Nikunj Chemicals, Shiva Inorganics, Huzhou Zhanwang Pharmaceutical Co. Ltd., China Shuanghua Gypsum, Jingmen City Leixin Gypsum

Which are the Top Profitable Regional Markets for the Pharma Grade Calcium Sulphate Industry?
North America was the largest region in the pharma grade calcium sulphate market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharma grade calcium sulphate market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24372

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.